EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Infant Acid‐Suppressant Medication, C. difficile Colonisation, and Childhood Body Mass Index in a Canadian Cohort

Sarah L Bridgman iD, Kelsea M Drall, Amanda A Lau, Hein M Tun iD, Nadia P Morales-Lizcano, Hien Q Huynh iD, Piushkumar J Mandhane, Theo J Moraes iD, Elinor Simons, Stuart E Turvey iD, Padmaja Subbarao iD, James A Scott und 1 weitere

Acta Paediatrica · 2025

DOI: 10.1111/apa.70243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Sarah L Bridgman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Histamine H2 Antagonists, Body Mass Index, Proton Pump Inhibitors, Clostridioides difficile. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, The Canadian Healthy Infant Longitudinal Development study, the Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To determine relationships between paediatric use of acid‐suppressive medications (ASMs) (proton pump inhibitors (PPI) and histamine‐2 receptor antagonists (H2RA)) and preschool body mass index (BMI) and mediation by C. difficile colonisation.

Methods

ASMs were parent‐reported at age 3, 6 and 12 months in 1025 infants from the CHILD Cohort Study. Targeted qPCR for C. difficile was conducted in stool collected at 3 months, and age/sex adjusted BMI‐z scores were calculated at age 5 years. ASM use and BMI‐z score associations were assessed by regression, and mediation analyses were conducted.

Results

Approximately 4% of infants received H2RAs, most before age 3 months. C. difficile colonisation was twice as likely in 3‐month‐old infants receiving H2RAs (OR: 2.27, 95% CI: 1.13–4.51) and was associated with higher BMI‐z scores at age 5 years (β: 0.31, 95% CI: 0.16, 0.46). Mediation models showed an indirect positive effect of H2RA use on 5‐year BMI‐z scores, mediated through C. difficile colonisation (β: 0.065, 95% CI: 0.01, 0.13).

Conclusions

We found evidence of increased preschool BMI following H2RA use in infants that was mediated through C. difficile colonisation. Further study on ASM use in infancy, the gut microbiome, and pathways to body weight health outcomes is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histamine H2 AntagonistsBody Mass IndexProton Pump InhibitorsClostridioides difficileClostridium InfectionsHumansInfantMaleFemaleChild, PreschoolCanadaCohort Studies

Stichwörter der Autor:innen

C. difficileacid suppressant medicationbody mass indexmicrobiota

Substanzen

Histamine H2 AntagonistsProton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
  • The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Department of Pediatrics & Child Health, Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Sarah L Bridgman, Hein M Tun, Hien Q Huynh, Theo J Moraes, Stuart E Turvey, Padmaja Subbarao, Anita L Kozyrskyj

Förderung

  • CIHR
  • The Canadian Healthy Infant Longitudinal Development study
  • the Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence
  • Canadian Institutes of Health Research

Zitieren

APA

Bridgman, S. L., Drall, K. M., Lau, A. A., Tun, H. M., Morales-Lizcano, N. P., Huynh, H. Q., Mandhane, P. J., Moraes, T. J., Simons, E., Turvey, S. E., Subbarao, P., Scott, J. A., & Kozyrskyj, A. L. (2025). Infant Acid‐Suppressant Medication, C. difficile Colonisation, and Childhood Body Mass Index in a Canadian Cohort. Acta Paediatrica. https://doi.org/10.1111/apa.70243

Vancouver

Bridgman SL, Drall KM, Lau AA, Tun HM, Morales-Lizcano NP, Huynh HQ, et al. Infant Acid‐Suppressant Medication, C. difficile Colonisation, and Childhood Body Mass Index in a Canadian Cohort. Acta Paediatrica. 2025. doi:10.1111/apa.70243

BibTeX
@article{Bridgman2025,
  author = {Bridgman, Sarah L and Drall, Kelsea M and Lau, Amanda A and Tun, Hein M and Morales-Lizcano, Nadia P and Huynh, Hien Q and Mandhane, Piushkumar J and Moraes, Theo J and Simons, Elinor and Turvey, Stuart E and Subbarao, Padmaja and Scott, James A and Kozyrskyj, Anita L},
  title = {Infant Acid‐Suppressant Medication, C. difficile Colonisation, and Childhood Body Mass Index in a Canadian Cohort},
  journal = {Acta Paediatrica},
  year = {2025},
  doi = {10.1111/apa.70243}
}
Kostenlos starten →